Search

Search Constraints

You searched for: Author/Creator Menozzi, Alberto

Search Results

11. Complete versus culprit‐only strategy in older MI patients with multivessel disease. Issue 4 (16th February 2022)

13. Impact of angiographic coronary artery disease complexity on ischemic and bleeding risks and on the comparative effectiveness of zotarolimus-eluting vs. bare-metal stents in uncertain drug-eluting stent candidates. (15th February 2019)

14. Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience. Issue 2 (1st March 2018)

15. Implications of different criteria for percutaneous coronary intervention-related myocardial infarction on study results of three large phase III clinical trials: The CHAMPION experience. Issue 2 (March 2018)

16. Left atrial appendage occlusion in patients with atrial fibrillation and large prevalence of prior intracranial bleeding. Issue 8 (August 2020)

17. Long‐term outcome in patients with ST segment elevation myocardial infarction and multivessel disease treated with culprit‐only, immediate, or staged multivessel percutaneous revascularization strategies: Insights from the REAL registry. Issue 6 (1st February 2014)

18. Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy. (15th March 2016)

19. Paclitaxel versus sirolimus eluting stents in diabetic patients: Does stent type and/or stent diameter matter?: Long‐term clinical outcome of 2, 429‐patient multicenter registry1. Issue 1 (8th November 2012)

20. Paclitaxel‐ and sirolimus‐eluting stents in older patients with diabetes mellitus. Issue 7 (26th February 2013)